
|Videos|February 9, 2017
A Study of Chemotherapy With Durvalumab and Tremelimumab in NSCLC
Author(s)Rosalyn Juergens, MD, PhD
Rosalyn Juergens, MD, PhD, assistant professor, Department of Oncology, Division of Medical Oncology, McMaster University, discusses a clinical trial investigating chemotherapy with durvalumab and tremelimumab in patients with non-small cell lung cancer (NSCLC).



















